Market revenue in 2022 | USD 5,799.0 million |
Market revenue in 2030 | USD 8,153.5 million |
Growth rate | 4.4% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 94.32% in 2024. Horizon Databook has segmented the North America menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The aging millennial population and growing prevalence of menopausal symptoms, such as hot flashes, are expected to drive the market in the region. Moreover, to cater to the increasing demand, ecommerce platforms and stores are providing dietary supplements targeted to ease menopausal symptoms. Significant adverse effects associated with HRT are leading to a decline in its adoption and a consequent increase in the adoption of dietary supplements.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account